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Introduction
Cryopyrin-associated periodic syndrome (CAPS) includes
three overlapping disorders: familial cold autoinflamma-
tory syndrome (FCAS), Muckle-Wells syndrome (MWS)
and neonatal onset multisystem inflammatory disorder
(NOMID). Once considerate separate entities, these her-
editary autoinflammatory disorders have been found to
share a common genetic basis, pathogenesis and treatment
and are therefore now considered a continuous clinical
spectrum of a single entity. CAPS is caused by dominantly
inherited or de novo NRLP3 mutations
Objectives
The use of genetic methods for detecting somatic
NLRP3 mosaicism in adult onset CAPS phenotype
Patients & methods
A 53 year old male, Christian Arab from North Israel, suf-
fered for 2 years from an unclassified multi-system inflam-
matory disorder. Its chief features were weight loss, fever,
maculopapular skin eruption, arthritis, lymph node enlarge-
ment, hepatosplenomegaly, bone periosteal reaction, all
associated with a major acute phase response. The arthritis
was chronic, with disease flares lasting weeks to months.
He responded moderately well to high dose corticosteroids
but not to immunosuppressive agents including DMARDs,
anti TNF agents, rituximab, nor tocilizumab. Subsequently,
he developed a moto-sensory peripheral neuropathy of the
legs and sensorineural deafness. There was no evidence of
amyloidosis nor a relevant family history.
Results
No mutations in MEFV, nor for TRAPS and MVK were
found.
A variant in NRLP3 Tyr 570 Cys (Y750C) was found
in peripheral blood cells and buccal mucosa.
The patient was treated with anti-IL-1 drugs. Anakinra
was poorly tolerated and then switched to canakinumab
300 mg / 4 weeks sc with complete remission of all symp-
toms except for the sensorineural deafness and peripheral
neuropathy.
Conclusion
The detection of somatic mosaicism can have major clini-
cal implications for patients including access to efficacious
treatment duly recognized by regulators, and more avail-
ability of needed frequent monitoring. Taking into account
the patient’s excellent response to IL -1 blockade, it is rea-
sonable to hypothesize that its earlier institution might
have prevented the appearance of the severe complications
of deafness and neuropathy.
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